Porat K

Language: Spanish
References: 11
Page: 57-60
PDF size: 276.16 Kb.

ABSTRACT

Melasma is a common, acquired, mostly symmetric hypermelanosis characterized by irregular, light-to-gray to darkbrown macules and patches with well-defined margins. It involves sun-exposed areas of the skin, most commonly the face and arms. Different treatment options are currently available for melasma. Despite the large number of depigmenting agents available, the treatment of hyperpigmentation is still a challenge for dermatologists.

REFERENCES

1. Bope. Conn’s Current Therapy 2010, primera edición. Saunders, an Imprint of Elsevier, 2009.

2. Cleveland Clinic. Current Clinical Medicine. Segunda edición. Saunders, an Imprint of Elsevier, 2010.

3. Falabella, R. Victoria, j. Barona, M. Domínguez, L. Fundamentos de Medicina – Dermatología. Sexta Edición. Corporación para investigaciones biológicas, Medellín, Colombia, 2002.

4. Gabbe. Obstetrics: Normal and Problem Pregnancies. Quinta edición. Churchill Livingstone, an Imprint of Elsevier, 2007.

5. Habif. Clinical Dermatology. Quinta edición. Mosby, El sevier, 2009.

6. Nicolaidou, E, Antoniou, C. Katsambas, A. Origin, Clinical Presentation, and Diagnosis of Facial Hypermelanoses. Dermatol Clin 25 (2007) 321–326.

7. Paul T. Rose, MD, JD. Pigmentary Disorders. Medical Clinics of North America - Volume 93, Issue 6. November 2009.

8. Picardo, M, Carrera, M. New and Experimental Treatments of Cloasma and Other Hypermelanoses. Dermatol Clin 25 (2007) 353–362.

9. Prignano, F. Ortonne, JP, Buggiani, G, Lotti, T. Therapeutical Approaches in Melasma. Dermatol Clin 25 (2007) 337–342.

10. Rubin, M. Exfoliación química. Dermatología estética. El Sevier, España. 2007.

11. Wolff, Goldsmith, Katz, Gilchrest, Peller, Leffell. Fitzpatirck Darmatología en Medicina General. Séptima Edición. Tercer tomo. Panamericana, España. 2008.